Guru Ownership Trend
Guru Analysis for CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $524.22 M.
Top institutional holders include Catherine Wood and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $25.42 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 31.3%. Conversely, Catherine Wood reduced exposure by 3.9%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 3.78% | Reduce -3.9% | 9,786,973 | $634.29 M | Q3 2025 | |
| 0.00% | Add 31.3% | 28,372 | $1.84 M | Q3 2025 | |
| 0.01% | Add 4.3% | 10,682 | $692,300 | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for CRISPR Therapeutics AG (CRSP)
Major holders include Catherine Wood ($634.29 M), Cliff Asness ($1.84 M), Murray Stahl ($692,300). According to the latest reported data, 3 tracked investment managers collectively hold approximately 9.83 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $25.42 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CRSP. The total reported sell value was $25.89 M.
Yes, 0 managers opened new positions in CRSP, and 2 increased their existing holdings. The total reported buy value was $466,697.19.